Le Lézard
Classified in: Health
Subject: PER

NYU Langone Hospital-Brooklyn Addresses Growing Need for Specialized Gastrointestinal Treatment in the Borough


BROOKLYN, N.Y., Feb. 11, 2019 /PRNewswire/ -- Sam Serouya, MD, a gastroenterologist specializing in advanced therapeutic endoscopy?which allows direct evaluation of the gastrointestinal (GI) tract and non-invasive treatment of digestive disorders and diseases?recently joined the medical staff at NYU Langone Hospital?Brooklyn.

Sam Serouya, MD, joins NYU Langone Hospital?Brooklyn as a gastroenterologist specializing in advanced therapeutic endoscopy.

Serouya is proficient in using state-of-the-art tools and performing leading-edge endoscopic procedures to detect and treat precancerous and cancerous growths. He joins a highly trained team of gastroenterologists headed by Adam J. Goodman, MD, chief of gastroenterology and director of endoscopy and quality in the Department of Medicine at NYU Langone Hospital?Brooklyn. The team works collaboratively with surgeons, oncologists, radiologists, and a variety of disease specialists to provide patients with innovative minimally invasive approaches to treatment.

NYU Langone Hospital?Brooklyn offers the latest generation of technologies for upper and lower endoscopy (including colonoscopy) of the GI tract, which includes the mouth, esophagus, stomach, and intestines, as well as nearby organs like the liver, pancreas, and bile duct. Advanced endoscopy includes endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), and a wide range of endoscopic surgical procedures.

"These technologies provide a detailed image of the lining and walls of the digestive tract, as well as surrounding tissues, and these procedures allow direct evaluation and innovative treatment of digestive problems," says Serouya. "Advanced endoscopy is a cutting-edge field that is constantly expanding to provide more and more modalities for the diagnosis and treatment of both benign and malignant conditions."

A stellar student, Serouya graduated summa cum laude and earned Phi Beta Kappa honors as a pre-med undergraduate at Tufts University in Boston. He completed his medical education at NYU School of Medicine, followed by an internship and residency in internal medicine at NYU Langone Medical Center. Additionally, he completed a three-year gastroenterology fellowship at Mount Sinai Beth Israel and a one-year advanced endoscopy fellowship at Montefiore Medical Center.

Serouya cautions that certain GI symptoms should not be ignored, including yellowing of the eyes or skin; abdominal pain, weight loss, blood with vomiting or defecation, pain with swallowing, sense of bloating. Any of these conditions should be brought to the attention of a primary care provider who can make a referral to a specialist in gastroenterology.

Serouya's office is located at NYU Langone Hospital?Brooklyn Medical Arts Pavilion, 8714 Fifth Avenue, Brooklyn, NY 11209, and he will also see patients at NYU Langone Levit Medical, 1220 Avenue P, Brooklyn, NY 11229. To make an appointment, please call 718-630-8600 or visit https://nyulangone.org/doctors/1013208859/sam-serouya.

Contact:

Colin DeVries
718-630-7414
[email protected]

(PRNewsfoto/NYU School of Medicine)

SOURCE NYU Langone Hospital-Brooklyn


These press releases may also interest you

at 09:20
Propanc Biopharma, Inc. ("Propanc" or the "Company"), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a certificate of grant for the Company's...

at 09:17
Change in the employee benefits space is a given. Companies that work with insurance brokers and consultants always have questions. So, it's important to know which questions to ask and how to frame them to find the right broker/consultant to...

at 09:15
Kane Biotech Inc. ("Kane") announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern Time. Marc Edwards, Kane's President & CEO, will share his thoughts on what the sale of STEM Animal Health, which should...

at 09:15
NMDP BioTherapies?, formerly Be The Match BioTherapies, a leader in cell and gene therapy development support, unveiled substantial upgrades to its cellular starting material offerings, including incorporating a Drug Master File (DMF) with its...

at 09:15
PulsePoint, a technology company revolutionizing health decision-making, announced the availability of new social capabilities to engage and measure authenticated healthcare professionals (HCPs) during brand-relevant moments on Meta ? the parent...

at 09:15
HedoniaUSA, a mental wellness company, announced the formation of its Scientific Board of Advisors. Currently developing a new medical food to address the unique nutritional needs associated with depression, the Advisors will help guide mental health...



News published on and distributed by: